ANIP
ANI Pharmaceuticals, Inc.
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2000-05-04
$72.28
+1.61 (+2.28%)
last quote
Want the full multi-source brief on ANIP?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$72.28
High
$72.37
Low
$70.99
Previous close
$70.67
Fundamentals
Market cap
$1.62B
P/E (TTM)
14.99x
P/S (TTM)
1.66x
P/B
3.28x
Gross margin
60.40%
Operating margin
15.37%
Net margin
11.07%
Rev growth (YoY)
30.90%
EPS growth (YoY)
—
ROE
19.64%
52W high
$95.57
52W low
$69.58
Beta
0.45x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-11-05todaybefore market
Q3 2026EPS est $2.22Rev est $285.8M
Recent SEC filings
CIK 1023024filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 1d
ANI Pharmaceuticals to Present at Upcoming November Investor Conferences
PRINCETON, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in presentations and fireside chats at the following upcoming investor conferences: EventGuggenheim 3rd Annual Healthcare Innovatio
Yahoo · 6d
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
NovoCure (NVCR) delivered earnings and revenue surprises of +57.14% and +5.50%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · 6d
3 market-beating stocks for long-term investors
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial